Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

BACKGROUND: Current treatment guidelines recommend adjuvant mitotane after resection of adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins, positive lymph nodes, high grade, elevated mitotic index, and advanced stage). Limited data exist on the outcomes associated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Coll Surg
Auteurs principaux: Postlewait, Lauren M, Ethun, Cecilia G, Tran, Thuy B, Prescott, Jason D, Pawlik, Timothy M, Wang, Tracy S, Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E, Keplinger, Kara, Fields, Ryan C, Jin, Linda X, Weber, Sharon M, Salem, Ahmed, Sicklick, Jason K, Gad, Shady, Yopp, Adam C, Mansour, John C, Duh, Quan-Yang, Seiser, Natalie, Solorzano, Carmen C, Kiernan, Colleen M, Votanopoulos, Konstantinos I, Levine, Edward A, Staley, Charles A, Poultsides, George A, Maithel, Shishir K
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957938/
https://ncbi.nlm.nih.gov/pubmed/26775162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2015.12.013
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires